XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

RESTATEMENT OF PREVIOUSLY ISSUED UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Accounting Changes and Error Corrections [Abstract] |
SCHEDULE OF RESTATEMENTS OF THE COMPANY’S UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS | The following tables present the effects of the Restatement on the Company’s unaudited interim condensed consolidated balance sheets as of the dates indicated: SCHEDULE OF RESTATEMENTS OF THE COMPANY’S UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS
|  | As Previously |  |  | Restatement |  |  | As |
|  | March 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 14,205,418 |  |  | $ | 14,205,418 |
Total current liabilities |  | $ | 493,829 |  |  | $ | 14,205,418 |  |  | $ | 14,699,247 |
Total liabilities |  | $ | 762,186 |  |  | $ | 14,205,418 |  |  | $ | 14,967,604 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 159,103,184 |  |  | $ | (21,901,000 | ) |  | $ | 137,202,184 |
Accumulated deficit |  | $ | (138,962,278 | ) |  | $ | 7,695,582 |  |  | $ | (131,266,696 | )
Total stockholders’ equity |  | $ | 20,156,702 |  |  | $ | (14,205,418 | ) |  | $ | 5,951,284 |
Total liabilities and stockholders’ equity |  | $ | 20,918,888 |  |  | $ | - |  |  | $ | 20,918,888 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | June 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 6,430,025 |  |  | $ | 6,430,025 |
Total current liabilities |  | $ | 621,781 |  |  | $ | 6,430,025 |  |  | $ | 7,051,806 |
Total liabilities |  | $ | 855,841 |  |  | $ | 6,430,025 |  |  | $ | 7,285,866 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 162,207,334 |  |  | $ | (21,901,000 | ) |  | $ | 140,306,334 |
Accumulated deficit |  | $ | (143,637,519 | ) |  | $ | 15,470,975 |  |  | $ | (128,166,544 | )
Total stockholders’ equity |  | $ | 18,585,612 |  |  | $ | (6,430,025 | ) |  | $ | 12,155,587 |
Total liabilities and stockholders’ equity |  | $ | 19,441,453 |  |  | $ | - |  |  | $ | 19,441,453 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | September 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 7,220,748 |  |  | $ | 7,220,748 |
Total current liabilities |  | $ | 717,179 |  |  | $ | 7,220,748 |  |  | $ | 7,937,927 |
Total liabilities |  | $ | 915,903 |  |  | $ | 7,220,748 |  |  | $ | 8,136,651 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 165,281,862 |  |  | $ | (21,901,000 | ) |  | $ | 143,380,862 |
Accumulated deficit |  | $ | (148,293,344 | ) |  | $ | 14,680,252 |  |  | $ | (133,613,092 | )
Total stockholders’ equity |  | $ | 17,004,315 |  |  | $ | (7,220,748 | ) |  | $ | 9,783,567 |
Total liabilities and stockholders’ equity |  | $ | 17,920,218 |  |  | $ | - |  |  | $ | 17,920,218 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | March 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 7,030,083 |  |  | $ | 7,030,083 |
Total current liabilities |  | $ | 470,391 |  |  | $ | 7,030,083 |  |  | $ | 7,500,474 |
Total liabilities |  | $ | 593,927 |  |  | $ | 7,030,083 |  |  | $ | 7,624,010 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 171,796,596 |  |  | $ | (21,901,000 | ) |  | $ | 149,895,596 |
Accumulated deficit |  | $ | (158,325,119 | ) |  | $ | 14,870,917 |  |  | $ | (143,454,202 | )
Total stockholders’ equity |  | $ | 13,487,037 |  |  | $ | (7,030,083 | ) |  | $ | 6,456,954 |
Total liabilities and stockholders’ equity |  | $ | 14,080,964 |  |  | $ | - |  |  | $ | 14,080,964 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | June 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 9,758,930 |  |  | $ | 9,758,930 |
Total current liabilities |  | $ | 812,853 |  |  | $ | 9,758,930 |  |  | $ | 10,571,783 |
Total liabilities |  | $ | 896,433 |  |  | $ | 9,758,930 |  |  | $ | 10,655,363 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 173,695,154 |  |  | $ | (21,901,000 | ) |  | $ | 151,794,154 |
Accumulated deficit |  | $ | (161,305,671 | ) |  | $ | 12,142,070 |  |  | $ | (149,163,601 | )
Total stockholders’ equity |  | $ | 12,403,864 |  |  | $ | (9,758,930 | ) |  | $ | 2,644,934 |
Total liabilities and stockholders’ equity |  | $ | 13,300,297 |  |  | $ | - |  |  | $ | 13,300,297 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | September 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 2,065,177 |  |  | $ | 2,065,177 |
Total current liabilities |  | $ | 932,619 |  |  | $ | 2,065,177 |  |  | $ | 2,997,796 |
Total liabilities |  | $ | 975,033 |  |  | $ | 2,065,177 |  |  | $ | 3,040,210 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 177,042,781 |  |  | $ | (21,901,000 | ) |  | $ | 155,141,781 |
Accumulated deficit |  | $ | (164,231,163 | ) |  | $ | 19,835,823 |  |  | $ | (144,395,340 | )
Total stockholders’ equity |  | $ | 12,826,068 |  |  | $ | (2,065,177 | ) |  | $ | 10,760,891 |
Total liabilities and stockholders’ equity |  | $ | 13,801,101 |  |  | $ | - |  |  | $ | 13,801,101 |
The following tables present the effect of the Restatement on the Company’s unaudited interim condensed consolidated statements of operations for the periods indicated:
|  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |
|  | March 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | 3,391,212 |  |  | $ | 3,391,212 |
Total other (income) expense |  | $ | (237,643 | ) |  | $ | 3,391,212 |  |  | $ | 3,153,569 |
Net loss |  | $ | (4,816,150 | ) |  | $ | (3,391,212 | ) |  | $ | (8,207,362 | )
Earnings (loss) per share - basic and diluted |  | $ | (1.37 | ) |  | $ | (0.96 | ) |  | $ | (2.33 | )
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |  |  | For the Six Months Ended |
|  | June 30, 2022 |  |  | June 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |  |  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |  |  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | (7,775,393 | ) |  | $ | (7,775,393 | ) |  | $ | - |  |  | $ | (4,384,181 | ) |  | $ | (4,384,181 | )
Total other (income) expense |  | $ | 46,613 |  |  | $ | (7,775,393 | ) |  | $ | (7,728,780 | ) |  | $ | (191,030 | ) |  | $ | (4,384,181 | ) |  | $ | (4,575,211 | )
Net (loss) income |  | $ | (4,675,241 | ) |  | $ | 7,775,393 |  |  | $ | 3,100,152 |  |  | $ | (9,491,391 | ) |  | $ | 4,384,181 |  |  | $ | (5,107,210 | )
Earnings (loss) per share - basic: |  | $ | (1.28 | ) |  | $ | 2.14 |  |  | $ | 0.85 |  |  | $ | (2.65 | ) |  | $ | 1.22 |  |  | $ | (1.43 | )
Weighted average common shares oustanding - diluted |  |  | 3,638,383 |  |  |  | 5,818,645 |  |  |  | 9,457,028 |  |  |  | 3,581,110 |  |  |  | - |  |  |  | 3,581,110 |
Earnings (loss) per share - diluted |  | $ | (1.28 | ) |  | $ | 0.82 |  |  | $ | 0.33 |  |  | $ | (2.65 | ) |  | $ | 1.22 |  |  | $ | (1.43 | )
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |  |  | For the Nine Months Ended |
|  | September 30, 2022 |  |  | September 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |  |  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |  |  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | 790,723 |  |  | $ | 790,723 |  |  | $ | - |  |  | $ | (3,593,458 | ) |  | $ | (3,593,458 | )
Total other expense (income) |  | $ | 46,125 |  |  | $ | 790,723 |  |  | $ | 836,848 |  |  | $ | (144,905 | ) |  | $ | (3,593,458 | ) |  | $ | (3,738,363 | )
Net (loss) income |  | $ | (4,655,825 | ) |  | $ | (790,723 | ) |  | $ | (5,446,548 | ) |  | $ | (14,147,216 | ) |  | $ | 3,593,458 |  |  | $ | (10,553,758 | )
Earnings (loss) per share - basic and diluted |  | $ | (1.28 | ) |  | $ | (0.22 | ) |  | $ | (1.50 | ) |  | $ | (3.93 | ) |  | $ | 1.00 |  |  | $ | (2.93 | )
|  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |
|  | March 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | 1,488,350 |  |  | $ | 1,488,350 |
Total other income |  | $ | (94,876 | ) |  | $ | 1,488,350 |  |  | $ | 1,393,474 |
Net (loss) income |  | $ | (5,684,222 | ) |  | $ | (1,488,350 | ) |  | $ | (7,172,572 | )
Earnings (loss) per share - basic and diluted |  | $ | (1.53 | ) |  | $ | (0.40 | ) |  | $ | (1.93 | )
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |  |  | For the Six Months Ended |
|  | June 30, 2023 |  |  | June 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |  |  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |  |  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | 2,728,847 |  |  | $ | 2,728,847 |  |  | $ | - |  |  | $ | 4,217,197 |  |  | $ | 4,217,197 |
Total other income |  | $ | (135,999 | ) |  | $ | 2,728,847 |  |  | $ | 2,592,848 |  |  | $ | (230,875 | ) |  | $ | 4,217,197 |  |  | $ | 3,986,322 |
Net (loss) income |  | $ | (2,980,552 | ) |  | $ | (2,728,847 | ) |  | $ | (5,709,399 | ) |  | $ | (8,664,774 | ) |  | $ | (4,217,197 | ) |  | $ | (12,881,971 | )
Earnings (loss) per share - basic and diluted |  | $ | (0.77 | ) |  | $ | (0.70 | ) |  | $ | (1.47 | ) |  | $ | (2.28 | ) |  | $ | (1.11 | ) |  | $ | (3.39 | )
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | For the Three Months Ended |  |  | For the Nine Months Ended |
|  | September 30, 2023 |  |  | September 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |  |  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |  |  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |  |  | (unaudited) |  |  |  |  |  | (unaudited) |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | (7,693,753 | ) |  | $ | (7,693,753 | ) |  | $ | - |  |  | $ | (3,476,556 | ) |  | $ | (3,476,556 | )
Total other income |  | $ | (178,951 | ) |  | $ | (7,693,753 | ) |  | $ | (7,872,704 | ) |  | $ | (409,826 | ) |  | $ | (3,476,556 | ) |  | $ | (3,886,382 | )
Net (loss) income |  | $ | (2,925,492 | ) |  | $ | 7,693,753 |  |  | $ | 4,768,261 |  |  | $ | (11,590,266 | ) |  | $ | 3,476,556 |  |  | $ | (8,113,710 | )
Earnings (loss) per share - basic: |  | $ | (0.64 | ) |  | $ | 1.68 |  |  | $ | 1.04 |  |  | $ | (2.85 | ) |  | $ | 0.85 |  |  | $ | (2.00 | )
Weighted average common shares oustanding - diluted |  |  | 4,570,843 |  |  |  | 7,753,923 |  |  |  | 12,324,766 |  |  |  | 4,061,975 |  |  |  | - |  |  |  | 4,061,975 |
Earnings (loss) per share - diluted |  | $ | (0.64 | ) |  | $ | 1.03 |  |  | $ | 0.39 |  |  | $ | (2.85 | ) |  | $ | 0.85 |  |  | $ | (2.00 | )
The following tables present the effect of the Restatement on the Company’s unaudited interim condensed consolidated statements of changes in stockholders’ equity for the periods indicated:
|  | Additional |  |  |  |  |  |  |
|  | Paid-In |  |  | Accumulated |  |  |  |
|  | Capital |  |  | Deficit |  |  | Total |
Balance - March 31, 2022 (as previously reported) |  | $ | 159,103,184 |  |  | $ | (138,962,278 | ) |  | $ | 20,156,702 |
Adjustment due to cumulative error correction |  |  | (21,901,000 | ) |  |  | 11,086,794 |  |  |  | (10,814,206 | )
Change in fair value of derivative liability |  |  | - |  |  |  | (3,391,212 | ) |  |  | (3,391,212 | )
Balance - March 31, 2022 (as restated) |  | $ | 137,202,184 |  |  | $ | (131,266,696 | ) |  | $ | 5,951,284 |
Balance - June 30, 2022 (as previously reported) |  | $ | 162,207,334 |  |  | $ | (143,637,519 | ) |  | $ | 18,585,612 |
Adjustment due to cumulative error correction |  |  | (21,901,000 | ) |  |  | 11,086,794 |  |  |  | (10,814,206 | )
Change in fair value of derivative liability |  |  | - |  |  |  | 4,384,181 |  |  |  | 4,384,181 |
Balance - June 30, 2022 (as restated) |  | $ | 140,306,334 |  |  | $ | (128,166,544 | ) |  | $ | 12,155,587 |
Balance - September 30, 2022 (as previously reported) |  | $ | 165,281,862 |  |  | $ | (148,293,344 | ) |  | $ | 17,004,315 |
Adjustment due to cumulative error correction |  |  | (21,901,000 | ) |  |  | 11,086,794 |  |  |  | (10,814,206 | )
Change in fair value of derivative liability |  |  | - |  |  |  | 3,593,458 |  |  |  | 3,593,458 |
Balance - September 30, 2022 (as restated) |  | $ | 143,380,862 |  |  | $ | (133,613,092 | ) |  | $ | 9,783,567 |
The following tables present the effect of the Restatement on the Company’s unaudited interim condensed consolidated statements of cash flows for the periods indicated:
|  |  |  |  |  |  |  | (unaudited) |
|  | March 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  |  |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (4,816,150 | ) |  | $ | (3,391,212 | ) |  | $ | (8,207,362 | )
Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | 3,391,212 |  |  | $ | 3,391,212 |
Net Cash Used In Operating Activities |  | $ | (1,594,634 | ) |  | $ | - |  |  | $ | (1,594,634 | )
|  | (unaudited) |  |  |  |  |  | (unaudited) |
|  | June 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (9,491,391 | ) |  | $ | 4,384,181 |  |  | $ | (5,107,210 | )
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | (4,384,181 | ) |  | $ | (4,384,181 | )
Net Cash Used In Operating Activities |  | $ | (2,845,756 | ) |  | $ | - |  |  | $ | (2,845,756 | )
|  | (unaudited) |  |  |  |  |  | (unaudited) |
|  | September 30, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (14,147,216 | ) |  | $ | 3,593,458 |  |  | $ | (10,553,758 | )
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | (3,593,458 | ) |  | $ | (3,593,458 | )
Net Cash Used In Operating Activities |  | $ | (4,297,412 | ) |  | $ | - |  |  | $ | (4,297,412 | )
|  | (unaudited) |  |  |  |  |  | (unaudited) |
|  | March 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (5,684,222 | ) |  | $ | (1,488,350 | ) |  | $ | (7,172,572 | )
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | 1,488,350 |  |  | $ | 1,488,350 |
Net Cash Used In Operating Activities |  | $ | (2,348,740 | ) |  | $ | - |  |  | $ | (2,348,740 | )
|  | (unaudited) |  |  |  |  |  | (unaudited) |
|  | June 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (8,664,774 | ) |  | $ | (4,217,197 | ) |  | $ | (12,881,971 | )
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | 4,217,197 |  |  | $ | 4,217,197 |
Net Cash Used In Operating Activities |  | $ | (3,479,065 | ) |  | $ | - |  |  | $ | (3,479,065 | )
|  | (unaudited) |  |  |  |  |  | (unaudited) |
|  | September 30, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
|  | (unaudited) |  |  |  |  |  | (unaudited) |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (11,590,266 | ) |  | $ | 3,476,556 |  |  | $ | (8,113,710 | )
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | (3,476,556 | ) |  | $ | (3,476,556 | )
Net Cash Used In Operating Activities |  | $ | (4,656,785 | ) |  | $ | - |  |  | $ | (4,656,785 | )

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration